Skip to main content

Table 1 abstract

From: Secondary prevention following surgical revascularisation: continuing under-use of angiotensin-converting enzyme inhibitors

 

2003

2004

2005

2006

Total

522

758

767

702

Previous myocardial infarction

296 (56.7%)

364 (48%)

353 (46%)

347 (49.4%)

Left ventricular systolic dysfunction

113 (21.6%)

145 (19.1%)

175 (22.8%)

186 (26.5%)

EuroSCORE

3.8 (2.7)

3.9 (3)

3.9 (2.8)

4.3 (2.9)

Aspirin

490 (93.9%)

694 (91.6%)

700 (91.3%)

652 (92.9%)

ACE inhibitor/angiotensin receptor blocker

285/34 (61%)

421/43 (61%)

430/53 (63%)

382/49 (61%)

β-Blocker

412 (78.9%)

632 (83.4%)

587 (76.5%)

540 (76.9%)

Statin

470 (90%)

700 (92.3%)

710 (92.6%)

638 (90.9%)